Home > M&A deals 2019 > Elligo Health Research, Inc. acquires Protenium Clinical Research
Add-on Acquistion · Life Science · January 2019

Elligo Health Research, Inc. acquires Protenium Clinical Research

On January 9, 2019, Elligo Health Research, Inc. acquired Protenium Clinical Research, a life science company in Texas, United States.

Deal at a glance

AnnouncedJanuary 9, 2019 TypeAdd-on Acquistion TargetProtenium Clinical Research Buyer Elligo Health Research, Inc. SectorLife Science LocationTexas, United States ValueNot disclosed

Target company

Protenium Clinical Research
Texas, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Elligo Health Research, Inc.
Company · 4 deals on record
  • 1st transaction in life science
  • 1st transaction in United States
4deals, all time
2in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Protenium Clinical Research?Elligo Health Research, Inc. acquired Protenium Clinical Research on January 9, 2019.

What type of deal was it?It was a add-on acquistion in the life science sector in 2019.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).